Silence Therapeutics is a biotechnology company that develops gene therapeutic technology based on RNA interference.

Pharmaceutical

Silence Therapeutics Plc

Silence Therapeutics Plc's headquarters in London, United Kingdom

Craig Tooman

Marie Wikström Lindholm

Curtis Rambaran

Jaimin B. Shah

Gianine Abbattista Esposito

John Paul Gabriel

J.P. Gabriel

John Strafford

Rhonda Hellums

James Ede-Golightly

Alistair Gray

Annemieke Aartsma-Rus

Henry Ginsberg

Gordon Duff

John Porter

John Whittaker

Michael H. Davidson

Tom Brown

Jenny Sims

Dave Lemus

Iain Ross

The Research and Development team at Silence Therapeutics Plc focuses on advancing RNA interference technologies to develop innovative gene therapies. This multidisciplinary group, comprising scientists and medical experts, works collaboratively to design, test, and refine drug candidates for various disease applications, ensuring rigorous scientific standards and effective drug discovery processes. Their efforts aim to translate cutting-edge research into viable therapeutic solutions.

Research and Development

The Leadership Team at Silence Therapeutics Plc is responsible for setting the strategic direction and vision of the company, overseeing the development and execution of its RNA interference gene therapeutic technologies. This diverse team, consisting of leaders from technical operations, medical research, finance, drug discovery, and regulatory affairs, collaboratively drives innovation and ensures that projects align with business goals while navigating the complex landscape of biopharmaceutical development.

Leadership Team

The Clinical Operations team at Silence Therapeutics Plc is responsible for overseeing the planning, execution, and management of clinical trials for RNA interference-based therapies. This team ensures compliance with regulatory standards, coordinates cross-functional collaboration, and drives the successful delivery of projects from conception through to regulatory approval, ultimately contributing to the advancement of innovative gene therapeutics.

Clinical Operations

The Finance and Administration team at Silence Therapeutics Plc is responsible for overseeing the company's financial planning, reporting, and human resources functions. This includes managing budgets, financial forecasting, and ensuring compliance with regulatory requirements, while also supporting talent acquisition, employee relations, and organizational development to foster a productive workplace. The team plays a critical role in aligning financial strategies with the company's mission to advance gene therapeutic technologies.

Finance and Administration

Silence Therapeutics Plc

Org chart

Board & advisors

Teams

Research and Development

Leadership Team

Clinical Operations

Finance and Administration

Offices

Silence Therapeutics Plc

Org chart

Board & advisors

Teams

Research and Development

Leadership Team

Clinical Operations

Finance and Administration

Offices

Related companies